Ascendis Pharma A/S
ASND | NASDAQ
$250.46
-$0.81 (-0.32%)
Nov 2, 2026, 12:32 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 210.4M | 639.69M | -33.25M | -60.99M | -38.86M | -94.63M | -38.47M | -99.2M | -109.38M | -131.04M | -86.88M | -162.22M | -121.43M | -110.91M | -207.42M | -168.96M | -81.32M | -125.5M | -106.06M | -80.35M | -134.37M | -62.79M |
Depreciation & Amortization | 4.64M | 4.29M | 4.78M | 4.02M | 4.31M | 4.55M | 4.48M | 4.37M | 4.39M | 4.48M | 4.98M | 4.74M | 4.65M | 4.55M | 4.64M | 4.52M | 4.39M | 4.42M | 4.27M | 3.78M | 3.62M | 3.71M |
Stock-Based Compensation | n/a | n/a | n/a | 30.64M | 30.02M | 25.56M | 26.22M | 26M | 26.05M | 17.28M | 15.91M | 17.18M | 19.88M | 13.69M | 13.87M | 13.54M | 16.8M | 19.97M | 14.15M | 13.29M | 16.32M | 23.08M |
Other Working Capital | 34.71M | 3.47M | 25.49M | 48.2M | 14.27M | -50.08M | 110.58M | 74.21M | 7.26M | -16.8M | 22.53M | 10.71M | -18.37M | 5.79M | 23.8M | 27.93M | 5.86M | -9.4M | -12.58M | 42.88M | -13.28M | 16.14M |
Other Non-Cash Items | 27.19M | -583.9M | 57.33M | 229K | 37.36M | -1.34M | -36.1M | -76.22M | 40.13M | 57.03M | 32.94M | 38.97M | -19.25M | -31.66M | 50.23M | 27.34M | -57.91M | -1.07M | -5.48M | -16.59M | 16.73M | -61.67M |
Deferred Income Tax | n/a | n/a | 3.22M | 3.62M | 3.85M | 1.06M | 1.09M | n/a | 229K | 2.51M | 5.79M | 645K | -429K | 1.3M | 5.35M | -167K | -46K | 241K | -114K | 6K | -68K | -191K |
Change in Working Capital | 44.12M | -67.92M | 38.59M | 24.64M | -44.03M | 50.49M | -44.39M | 88.91M | -22.72M | -51.84M | -15.21M | -24.03M | -36.54M | -24M | -8.36M | 24.9M | -6.32M | -28.84M | -30.08M | -17.65M | -17.43M | 16.25M |
Operating Cash Flow | 286.35M | -7.85M | 70.67M | 2.15M | -7.34M | -14.31M | -87.18M | -56.13M | -61.31M | -101.58M | -42.47M | -124.72M | -153.13M | -147.04M | -141.69M | -98.83M | -124.39M | -130.79M | -123.31M | -97.52M | -115.2M | -81.62M |
Capital Expenditures | -3.24M | -7.84M | -3.3M | -53K | -4.34M | -703K | -383K | -467K | -342K | -199K | 63K | -976K | -444K | -1.09M | -3.78M | -3.16M | -3.73M | -3.82M | -4.8M | -11.3M | -3.58M | -4.56M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.19M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.28K | n/a | n/a | n/a | -53M | -71.14M | -63.39M | -26.31M | -138.49M | -11.19M | -36.91M | -39.44M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -1K | n/a | n/a | 7.35M | 6.58M | 23.15M | 47.4M | 211.73M | 55.99M | 88.4M | 71.26M | 64.88M | 31.37M | 42.91M | 51.53M | 24.07M |
Other Investing Acitivies | 382.05K | 974.77K | n/a | n/a | n/a | n/a | 36K | -36K | 950K | n/a | 5K | 46K | n/a | n/a | n/a | n/a | 5.74M | 3.79M | n/a | n/a | n/a | -530K |
Investing Cash Flow | -2.86M | -6.86M | -3.3M | -53K | -4.34M | -703K | -384K | -503K | 608K | 7.16M | 6.65M | 22.22M | 46.96M | 210.65M | -797K | 14.1M | 9.89M | 38.54M | -111.92M | 20.43M | 11.04M | -30.12M |
Debt Repayment | -8.22M | -8.72M | -6.67M | -6.57M | -5.49M | -3.07M | -2.95M | -2.81M | -2.82M | -2.79M | -6.26M | 137.16M | -2.52M | -2.57M | -1.78M | -1.41M | -2.39M | 502.5M | -1.54M | -1.51M | -1.41M | n/a |
Common Stock Repurchased | -52.06M | -52.71M | -90.01K | -588.32K | n/a | -17.4M | n/a | n/a | n/a | n/a | -1.81M | n/a | n/a | n/a | -2K | 1K | -150K | -105.15M | -21.61M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.79M | -8.15M | -58.96K | 1.43M | n/a | 2.44M | -16.26M | 430.69M | 365K | 21.21M | 2.02M | 6.19M | 208K | 1.87M | 3.13M | 1.34M | 301K | 385K | 2.33M | 4.43M | 2.8M | -2.01M |
Financial Cash Flow | -46.64M | -37.44M | 8.36M | 38.85M | 6.98M | -18.02M | 87K | 427.87M | -2.46M | 18.42M | -6.06M | 143.36M | -2.31M | -702K | 1.35M | -76K | -2.24M | 397.74M | -20.63M | 370.61M | 1.39M | 20.47K |
Net Cash Flow | 234.88M | -55.17M | 76.66M | 45.05M | -23.88M | -41.62M | -65.97M | 366.82M | -61.54M | -71.93M | -49.1M | 47.05M | -107.06M | 56.51M | -163.56M | -64.06M | -83.26M | 309.38M | -246.67M | 308.4M | -110.51M | -89.47M |
Free Cash Flow | 283.11M | -15.69M | 67.37M | 2.1M | -11.68M | -15.02M | -87.56M | -56.6M | -61.65M | -101.78M | -42.41M | -125.7M | -153.57M | -148.13M | -145.47M | -102M | -128.12M | -134.61M | -128.11M | -108.82M | -118.78M | -86.17M |
Adj. Free Cash Flow | 283.11M | -15.69M | 67.37M | -28.54M | -41.7M | -40.57M | -113.78M | -82.6M | -87.7M | -119.06M | -58.32M | -142.88M | -173.45M | -161.82M | -159.34M | -115.53M | -144.92M | -154.57M | -142.25M | -122.11M | -135.1M | -109.25M |
Maintenance CapEx | -3.24M | -4.29M | n/a | n/a | n/a | n/a | n/a | n/a | -342K | n/a | 126K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.3M | -3.58M | -4.56M |
Growth CapEx | n/a | -3.55M | -3.3M | -53K | -4.34M | -703K | -383K | -467K | n/a | -199K | -63K | -976K | -444K | -1.09M | -3.78M | -3.16M | -3.73M | -3.82M | -4.8M | n/a | n/a | n/a |
Owner Earnings | 283.11M | -12.14M | 70.67M | 2.15M | -7.34M | -14.31M | -87.18M | -56.13M | -61.65M | -101.58M | -42.34M | -124.72M | -153.13M | -147.04M | -141.69M | -98.83M | -124.39M | -130.79M | -123.31M | -108.82M | -118.78M | -86.17M |
Add to Watchlist
Select watchlists to add or remove ASND